Portal Vein Tumor Thrombosis
📧 Sign up to get email alerts when something new happens for Portal Vein Tumor Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus [Phase 2]
A Phase 2 trial evaluating conversion therapy with FOLFOX-HAIC plus lenvatinib and tislelizumab for hepatocellular carcinoma with portal vei…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus [Phase 2]
A Phase 2 clinical trial is evaluating radiotherapy in combination with tislelizumab and anlotinib for hepatocellular carcinoma with portal …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT [Phase 2]
A Phase 2 clinical trial evaluating QL1706 in combination with Bevacizumab and RALOX-HAIC for hepatocellular carcinoma with portal vein tumo…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma
This clinical trial is evaluating whether PIVKA-II can predict portal vein tumor thrombosis in hepatocellular carcinoma and is currently rec…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT [NA]
A clinical trial is evaluating a combination of transarterial chemoembolization (TACE) with atezolizumab/bevacizumab and I-125 seed brachyth…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 1, Phase 2]
Clinical trial update evaluating SBRT with Cardonilizumab and Lenvastinib for unresectable hepatocellular carcinoma with portal vein tumor t…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: ISP-TACE Versus TACE for HCC With PVTT
A completed clinical trial comparing ISP-TACE with conventional transarterial chemoembolization (TACE) in hepatocellular carcinoma with port…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients [Phase 2]
This entry reports the completion of a Phase 2 clinical trial evaluating comprehensive treatment approaches for different types of tumor thr…
-
CLINICAL_TRIALS research · 2011-05-09Clinical Trial Update: Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis [Phase 4]
This clinical trial update outlines a Phase 4 comparison between surgical hepatic resection and transcatheter arterial chemoembolization (TA…